Global X Genomics & Biotechnology ETF (GNOM)
NASDAQ: GNOM · Real-Time Price · USD
49.76
+1.36 (2.81%)
At close: Jan 21, 2026, 4:00 PM EST
49.76
0.00 (0.00%)
After-hours: Jan 21, 2026, 4:15 PM EST
GNOM Holdings Information
GNOM is an equity ETF with a total of 50 individual holdings. The top holdings are Arrowhead Pharmaceuticals stock at 5.95%, Moderna at 5.77%, Guardant Health at 5.61%, Illumina at 5.54%, and Praxis Precision Medicines at 5.51%.
Total Holdings
50
Top 10 Percentage
48.41%
Asset Class
Equity
ETF Category
Health
Assets
52.40M
PE Ratio
n/a
Sector Allocation
Top 25 Holdings
| No. | Symbol | Name | % Weight |
|---|---|---|---|
| 1 | ARWR | Arrowhead Pharmaceuticals, Inc. | 5.95% |
| 2 | MRNA | Moderna, Inc. | 5.77% |
| 3 | GH | Guardant Health, Inc. | 5.61% |
| 4 | ILMN | Illumina, Inc. | 5.54% |
| 5 | PRAX | Praxis Precision Medicines, Inc. | 5.51% |
| 6 | NTRA | Natera, Inc. | 4.51% |
| 7 | TECH | Bio-Techne Corporation | 4.09% |
| 8 | BMRN | BioMarin Pharmaceutical Inc. | 3.85% |
| 9 | VRTX | Vertex Pharmaceuticals Incorporated | 3.81% |
| 10 | RNA | Avidity Biosciences, Inc. | 3.77% |
| 11 | BNTX | BioNTech SE | 3.72% |
| 12 | QGEN | Qiagen N.V. | 3.53% |
| 13 | CRSP | CRISPR Therapeutics AG | 3.14% |
| 14 | ALNY | Alnylam Pharmaceuticals, Inc. | 2.70% |
| 15 | VCYT | Veracyte, Inc. | 2.68% |
| 16 | LEGN | Legend Biotech Corporation | 2.49% |
| 17 | BEAM | Beam Therapeutics Inc. | 2.48% |
| 18 | BMY | Bristol-Myers Squibb Company | 2.41% |
| 19 | WGS | GeneDx Holdings Corp. | 2.35% |
| 20 | LLY | Eli Lilly and Company | 2.30% |
| 21 | LON: AZN | AstraZeneca PLC | 2.04% |
| 22 | TWST | Twist Bioscience Corporation | 2.02% |
| 23 | TXG | 10x Genomics, Inc. | 1.99% |
| 24 | GILD | Gilead Sciences, Inc. | 1.85% |
| 25 | RARE | Ultragenyx Pharmaceutical Inc. | 1.78% |
As of Jan 15, 2026